课题基金 / 基金详情

STUDIES ON INSULIN RECEPTOR ISO FORMS

STUDIES ON INSULIN RECEPTOR ISO FORMS
胰岛素受体异构体的研究
批准号:
10390085
负责人:
Danny Hung-Chieh Chou
金额:
$13.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2022-08-31

项目摘要

项目成果

Danny Hung-Chieh Chou的其他基金

相似基金

相关文献

中文摘要
翻译
胰岛素及其受体(IR)参与新陈代谢、增殖和分化。在……里面 在哺乳动物中,由于选择性剪接的不同,存在两种亚型(IR-A和IR-B)。尽管它是 文献表明IR-A的激活是“有丝分裂的”,而IR-B的激活是“代谢的”, 由于缺乏工具来研究IR异构体的生物学作用,因此具有挑战性 研究个体效应。在这里,我们建议开发异构体选择性胰岛素类似物通过使用一种 结构导向法与高通量筛选法相结合。这些异构体 选择性类似物将被开发用于研究探针,以剖析每种IR异构体的作用。这些 工具将使我们能够回答以下问题:1)IR异构体mRNA水平是否与 蛋白质水平?2)相同的细胞是否会有不同的异构体比率,以满足细胞的需求? IR异构体在体内的分布是否符合某种逻辑?4)每种IR异构体的作用是什么 在体内的每种细胞类型中?这一领域的研究进展可能会导致新的治疗策略 人类疾病。
英文摘要
Insulin and insulin receptor (IR) are involved in metabolism, proliferation and differentiation. In mammals, two isoforms (IR-A and IR-B) exist due to differences in alternative splicing. Although it was suggested in the literature that IR-A activation is “mitogenic” and IR-B activation is “metabolic”, in-depth investigations about the biological roles of the IR isoforms are challenging due to the lack of tools to study the individual effects. Here, we propose to develop isoform-selective insulin analogues by using a combination of structure-guided approach and a high-throughput screening approach. These iso-form selective analogues will be developed to research probes to dissect the roles of each IR isoform. These tools will enable us to answer the following questions: 1) Do IR isoform mRNA levels correlate with protein levels? 2) Could the same cell have different isoform ratio overtime to address cellular need? 3) Does IR isoform distribution in vivo follow some type of logic? and 4) What is the role of each IR isoform in each cell type in vivo? Research progress in this field may lead to new therapeutic strategies for human diseases.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Development of long-acting glucose-responsive insulin formulations
  • 批准号:
    10055540
  • 项目类别:
  • 资助金额:
    $64.38万
  • 财政年份:
    2020
  • 负责人:
    Danny Hung-Chieh Chou
  • 依托单位:
Development of long-acting glucose-responsive insulin formulations
  • 批准号:
    10202583
  • 项目类别:
  • 资助金额:
    $62.4万
  • 财政年份:
    2020
  • 负责人:
    Danny Hung-Chieh Chou
  • 依托单位:
Development of long-acting glucose-responsive insulin formulations
  • 批准号:
    10380689
  • 项目类别:
  • 资助金额:
    $63.92万
  • 财政年份:
    2020
  • 负责人:
    Danny Hung-Chieh Chou
  • 依托单位:
Development of long-acting glucose-responsive insulin formulations
  • 批准号:
    10613951
  • 项目类别:
  • 资助金额:
    $62.78万
  • 财政年份:
    2020
  • 负责人:
    Danny Hung-Chieh Chou
  • 依托单位:
海外基金